Gofen & Glossberg LLC Abb Vie Inc. Transaction History

Gofen & Glossberg LLC

$3.89 Billion
Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gofen & Glossberg LLC holds 325,692 shares of ABBV stock, worth $63 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

325,692

Previous 327,778 0.64%

Holding current value

$63 Million

Previous $44 Million 19.65%

% of portfolio

1.35%

Previous 1.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$138.31 - $165.87 $288,514 - $346,004	-2,086 Reduced 0.64%	325,692 $52.6 Million
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $14,494 - $16,624	108 Added 0.03%	327,778 $44 Million
Q2 2022 Jul 14, 2022	SELL	$137.62 - $174.96 $853,932 - $1.09 Million	-6,205 Reduced 1.86%	327,670 $50.2 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $261,716 - $324,716	-1,983 Reduced 0.59%	333,875 $54.1 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $2.21 Million - $2.8 Million	20,573 Added 6.53%	335,858 $45.5 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $2.06 Million - $2.34 Million	19,353 Added 6.54%	315,285 $34 Million
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $1.22 Million - $1.36 Million	11,619 Added 4.09%	295,932 $33.3 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $2.35 Million - $2.58 Million	22,943 Added 8.78%	284,313 $30.8 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $1.01 Million - $1.36 Million	12,558 Added 5.05%	261,370 $28 Million
Q3 2020 Oct 09, 2020	BUY	$85.91 - $100.83 $1.06 Million - $1.25 Million	12,355 Added 5.23%	248,812 $21.8 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $775,887 - $1.04 Million	10,575 Added 4.68%	236,457 $23.2 Million
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $929,832 - $1.41 Million	14,416 Added 6.82%	225,882 $17.2 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $170,803 - $213,712	-2,368 Reduced 1.11%	211,466 $18.7 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $1.35 Million - $1.62 Million	21,359 Added 11.1%	213,834 $16.2 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $1.52 Million - $1.95 Million	23,193 Added 13.7%	192,475 $14 Million
Q1 2019 Apr 11, 2019	SELL	$77.14 - $90.79 $441,240 - $519,318	-5,720 Reduced 3.27%	169,282 $13.6 Million
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $205,368 - $253,274	-2,638 Reduced 1.49%	175,002 $16.1 Million
Q3 2018 Oct 11, 2018	BUY	$88.91 - $98.84 $94,244 - $104,770	1,060 Added 0.6%	177,640 $16.8 Million
Q2 2018 Jul 11, 2018	SELL	$89.78 - $106.23 $497,022 - $588,089	-5,536 Reduced 3.04%	176,580 $16.4 Million
Q1 2018 Apr 11, 2018	SELL	$92.01 - $123.21 $608,554 - $814,910	-6,614 Reduced 3.5%	182,116 $17.2 Million
Q4 2017 Jan 11, 2018	SELL	$89.56 - $98.21 $570,318 - $625,401	-6,368 Reduced 3.26%	188,730 $18.3 Million
Q3 2017 Nov 16, 2017	SELL	$69.85 - $89.22 $610,139 - $779,336	-8,735 Reduced 4.29%	195,098 $17.3 Million
Q2 2017 Aug 16, 2017	BUY	N/A	203,833	203,833 $14.8 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Account

Gofen & Glossberg LLC Abb Vie Inc. Transaction History